Difference between revisions of "OHSU Knight Cancer Institute Research Groups:OCI Cancer Journal Club"

From OpenWetWare
Line 107: Line 107:
|Chuck Pham Jr
|Chuck Pham Jr
|Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells

Revision as of 13:58, 17 November 2011

Equipped with his five senses, man explores the universe around him and calls the adventure Science.  ~Edwin Powell Hubble, The Nature of Science, 1954

Home        Faculty        Graduate Program        Postdocs        OHSU Knight Core Facilities       

Programs     Res Group Meetings        Cancer Journal Club        Cell/CANB 616        Gen. Inst/R3 Club     CANB 610    

Objectives of the OHSU Cancer Biology Journal Club

Cross-departmental journal club composed of students, postdocs, fellows and clinical and basic science faculty with shared interest in basic principles, emerging discoveries, and new therapeutic approaches in Cancer Biology. The goals of the meetings are to:

  • Critically evaluate new cutting edge literature on mechanisms underlying the development and maintenance of cancer to inform the development of new therapeutics. Papers should be paradigm shifting and set a backdrop for discussion into therapeutics facilitated by the clinical attendees.
  • Provide students, postdocs and fellows with training and interactions with faculty interested in Cancer Biology and emerging therapeutics

KCI CJC Information

Want to join us? All are invited!

  • To get on the listserve:
Begin a new e-mail and address it to: majordomo@ohsu.edu (must be sent as a plain text email)
Type 'subscribe oncobio' into the subject line AND
Type 'subscribe oncobio' into the text box of the e-mail and send
  • To send out your paper
Send an e-mail to 'oncobio' with your paper attached
  • When and where we meet
MacHall 2136
Thursdays noon-1 PM
Lunch provided by KCI
  • Organizer contact information:
Rosie Sears-searsr@ohsu.edu
Charlie Lopez- lopezc@ohsu.edu

Member Labs and Affiliations

Lopez Lab Hem Onc

Sears Lab

Hoatlin Lab

Thayer Lab

Wong Lab

Lloyd Lab CROET

McCullough Lab CROET


  • Scheduling In Progress
Date Presenters Topic Links & Comments
9/29/2011 Charlie Lopez Organization
10/6/2011 xxxxxxxxxx CANCEL xxxxxxxxxx
10/13/2011 Xiaoli Zhang Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms PI3KCA mechanisms
10/20/2011 Rosie Sears Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis Goetz 2009
10/27/2011 Katy Van Hook Competative RNA Karreth (2011)
11/3/2011 Mushui Dai A Critical Role for Noncoding 5S rRNA in Regulating Mdmx Stability. Mol Cell. 2011 Sep 16;43(6):1023-32. http://www.sciencedirect.com/science/article/pii/S109727651100640X
11/10/2011 Charlie Lopez CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans science 2011 Beatty
11/17/2011 canceled
11/24/2011 xxxxxxxxxx THANKSGIVING, NO JOURNAL CLUB xxxxxxxxxx
12/1/2011 Aaron Wortham The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma Oricchio E et al 2011 Cell
12/8/2011 Myron Peto
12/15/2011 Chuck Pham Jr Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells http://www.mendeley.com/research/efficient-delivery-liposomemediated-mgmtsirna-reinforces-cytotoxity-temozolomide-gbminitiating-cells/
1/5/2012 Tim Butler
1/12/2012 Jared Fischer
1/19/2012 Yulong Su
1/26/2012 Yuangang Liu
2/2/2012 Mahnaz Janghorban
2/9/2012 Tiffany DeVine
2/16/2012 Jason Link
2/23/2012 Ellen Langer
3/1/2012 Aaron Jacobs
3/8/2012 Vince Bicocca
3/15/2012 John Oyer
4/5/2012 Kinrin Yamanaka
4/12/2012 Stacey Lin
4/19/2012 Juan Liang
4/26/2012 Jeff Wu
5/3/2012 Amy Farrell
5/10/2012 Xiaoxin Sun
5/17/2012 Nathalie Javidi-Sharifi
5/24/2012 Nichole Owen
5/31/2012 Zhiping Wang
6/7/2012 Kishore Challagundla